Cover Image
市場調查報告書

內分泌檢查市場(E2,FSH,hCG,LH,DHEAS,孕甾酮,睪酮(睪丸激素),TSH,催乳激素,皮質醇,胰島素檢驗及其他):全球產業分析、規模、市場佔有率、成長、趨勢及預測

Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

出版商 Transparency Market Research 商品編碼 294622
出版日期 內容資訊 英文 157 pages
商品交期: 最快1-2個工作天內
價格
Back to Top
內分泌檢查市場(E2,FSH,hCG,LH,DHEAS,孕甾酮,睪酮(睪丸激素),TSH,催乳激素,皮質醇,胰島素檢驗及其他):全球產業分析、規模、市場佔有率、成長、趨勢及預測 Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日期: 2014年01月31日 內容資訊: 英文 157 pages
簡介

本報告提供內分泌檢查市場相關調查,檢驗各類型,各技術,及各終端用戶趨勢,市場規模與未來預測,各地區趨勢,競爭環境等資料,連同企業簡介,為您概述為以下內容。

第1章 序論

第2章 摘要整理

第3章 市場概要

  • 概要
    • 內分泌系統的要素簡介
    • 內分泌檢查市場市場潛在性
    • 內分泌檢查市場未來方案
  • 市場趨勢
    • 推動市場的要素
      • 全球性糖尿病及肥胖患者數的增加
      • 全球性高齡人口的增加
      • 技術的進步
    • 阻礙市場的要素
      • 高成本的科技
      • 新興國家對醫療認識的不足
    • 市場機會
      • 投資的機會
  • 波特五力分析模式
  • 市場魅力度分析:各地區

第4章 內分泌檢查市場:檢查別

  • 雌激素(E2)檢驗
  • 濾泡刺激素(FSH)檢驗
  • 人類絨毛膜性腺激素(hCG)檢驗
  • 黃體激素(LH)檢驗
  • 脫氫異雄固酮(DHEAS)檢查
  • 孕甾酮檢驗
  • 睪酮(睪丸激素)檢驗
  • 甲狀腺刺激素(TSH)檢驗
  • 催乳激素檢驗
  • 皮質醇檢驗
  • 胰島素檢驗
  • 其他

第5章 內分泌檢查市場:各技術

  • 概要
  • 串聯式質譜分析
  • 免疫疾病化驗
  • 單株抗體及多株抗體技術
  • 感應技術
  • 臨床化學技術
  • 其他

第6章 內分泌檢查市場:各終端用戶

  • 概要
  • 醫院
  • 商業性實驗室
  • 門診病人照護中心
  • 家庭檢驗
  • 診療所

第7章 內分泌檢查市場:各地區

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第8章 競爭環境

  • 主要企業的市場佔有率

第9章 建議

  • 市場成功策略
  • 應該考慮的障礙

第10章 企業簡介

  • Abbott Laboratories
  • AB SCIEX LLC
  • Agilent Technologies
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad Laboratories, Inc.
  • DiaSorin S.p.A
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings (LabCorp)
  • Ortho Clinical Diagnostics
  • Quest Diagnostics
  • Siemens Healthcare
  • Sysmex Corporation
  • Thermo Fisher Scientific

圖表

目錄

Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices.

On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the endocrine testing market and future opportunities are provided in the report. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Several other analytical perspectives such as Porter's Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making.

The global endocrine testing market is segmented into the following categories:

Hernia Endocrine Testing Market, by Tests

  • Estradiol (E2) Test
  • Follicle Stimulating Hormone (FSH) Test
  • Human Chorionic Gonadotropin (hCG) Test
  • Luteinizing Hormone (LH) Test
  • Dehydroepiandrosterone sulfate (DHEAS) Test
  • Progesterone Test
  • Testosterone Test
  • Thyroid Stimulating Hormone (TSH) Test
  • Prolactin Test
  • Cortisol Test
  • Insulin Test
  • Others (Gastrin, Thymosin, Secretin, etc.)

Endocrine Testing Market, by Diagnostic Technologies

  • Tandem Mass spectrometry
  • Immunoassay (Enzyme immunoassays, Radioimmunoassays (RIA)) Technologies
  • Monoclonal and Polyclonal Antibody Technologies
  • Sensor (Electrochemical, Biosensors, etc.) Technologies
  • Clinical Chemistry Technologies
  • Others (Liquid Chromatography + Mass Spectrometry (LC-MS), High performance Liquid Chromatography (HPLC), etc.)

Endocrine Testing Market, by Geography

  • Hospitals
  • Commercial Laboratories
  • Ambulatory Care Centers
  • Home Based Tests
  • Physician Offices

Endocrine Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Sources
      • 1.3.1.1 Secondary Research
      • 1.3.1.2 Primary Research
      • 1.3.1.3 Models
      • 1.3.1.4 Assumptions
  • 1.4 List of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
  • 2.2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
  • 2.3 Global Endocrine Testing Market, by Diagnostic Technologies, 2012 (USD Million)

Chapter 3 Market Overview

  • 3.1 Overview
    • 3.1.1 Introduction to Elements of Endocrine System
    • 3.1.2 Market Potential of Endocrine Testing Market
    • 3.1.3 Future Scenario of Endocrine Testing Market
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers
      • 3.2.1.1 Increasing Incidence of diabetic and obese population worldwide
      • 3.2.1.2 Consistent rise in geriatric population Worldwide
      • 3.2.1.3 Technological advancements
    • 3.2.2 Market Restraints
      • 3.2.2.1 High cost of technology
      • 3.2.2.2 Lack of healthcare awareness in emerging economies
    • 3.2.3 Market Opportunity
      • 3.2.3.1 Investment opportunity
  • 3.3 Porter's Five Force Analysis for the Global Endocrine Testing Market
    • 3.3.1 Bargaining power of suppliers
    • 3.3.2 Bargaining power of buyers
    • 3.3.3 Threat of substitutes
    • 3.3.4 Threat of new entrants
    • 3.3.5 Competitive rivalry
  • 3.1 Market Attractiveness Analysis: Global Endocrine Technologies Market, by Geography

Chapter 4 Endocrine Testing Market, by Test

  • 4.1 Overview
    • 4.1.1 Global Endocrine Testing Market, by Test, 2011 - 2019 (USD Million)
  • 4.2 Estradiol (E2) Test
    • 4.2.1 Global Estradiol (E2) Test Market, 2011 - 2019 (USD Million)
  • 4.3 Follicle Stimulating Hormone (FSH) Test
    • 4.3.1 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 - 2019 (USD Million)
  • 4.4 Human Chorionic Gonadotropin (hCG) Test
    • 4.4.1 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 - 2019 (USD Million)
  • 4.5 Luteinizing Hormone (LH) Test
    • 4.5.1 Global Luteinizing Hormone (LH) Test Market, 2011 - 2019 (USD Million)
  • 4.6 Dehydroepiandrosterone Sulfate (DHEAS) Test
    • 4.6.1 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 - 2019 (USD Million)
  • 4.7 Progesterone Test
    • 4.7.1 Global Progesterone Test Market, 2011 - 2019 (USD Million)
  • 4.8 Testosterone Test
    • 4.8.1 Global Testosterone Test Market, 2011 - 2019 (USD Million)
  • 4.9 Thyroid Stimulating Hormone (TSH) Test
    • 4.9.1 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 - 2019 (USD Million)
  • 4.10 Prolactin Test
    • 4.10.1 Global Prolactin Test Market, 2011 - 2019 (USD Million)
  • 4.11 Cortisol Test
    • 4.11.1 Global Cortisol Test Market, 2011 - 2019 (USD Million)
  • 4.12 Insulin Test
    • 4.12.1 Global Insulin Test Market, 2011 - 2019 (USD Million)
  • 4.13 Others
    • 4.13.1 Global Others Market, 2011 - 2019 (USD Million)

Chapter 5 Endocrine Testing Market, by Diagnostic Technologies

  • 5.1 Overview
    • 5.1.1 Global Endocrine Testing Market, by Diagnostic Technologies 2011 - 2019 (USD Million)
  • 5.2 Tandem Mass Spectrometry
    • 5.2.1 Global Tandem Mass Spectrometry Market, 2011 - 2019 (USD Million)
  • 5.3 Immunoassay (Enzyme Linked Assays(EIA), Radio Immunoassay (RIA))Technologies
    • 5.3.1 Global Immunoassay Technologies Market, 2011 - 2019 (USD Million)
  • 5.4 Monoclonal and Polyclonal Antibody Technologies
    • 5.4.1 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 - 2019 (USD Million)
  • 5.5 Sensor Technologies
    • 5.5.1 Global Sensor Technologies Market, 2011 - 2019 (USD Million)
  • 5.6 Clinical Chemistry Technologies
    • 5.6.1 Global Clinical Chemistry Technologies Market, 2011 - 2019 (USD Million)
  • 5.7 Others ((Liquid Chromatography + Tandem Mass Spectrometry (LC-MS/MS), High performance Liquid Chromatography (HPLC), etc.)
    • 5.7.1 Global Others Market, 2011 - 2019 (USD Million)

Chapter 6 Endocrine Testing Market, by End Users

  • 6.1 Overview
    • 6.1.1 Global Endocrine Testing Market, by End Users 2011 - 2019 (USD Million)
  • 6.2 Hospitals
    • 6.2.1 Global Hospitals Market, 2011 - 2019 (USD Million)
  • 6.3 Commercial Laboratories
    • 6.3.1 Global Commercial Laboratories Market, 2011 - 2019 (USD Million)
  • 6.4 Ambulatory Care Centers
    • 6.4.1 Global Ambulatory Care Centers Market, 2011 - 2019 (USD Million)
  • 6.5 Home Based Tests
    • 6.5.1 Global Home Based Tests Market, 2011 - 2019 (USD Million)
  • 6.6 Physician Offices
    • 6.6.1 Global Physician Offices Market, 2011 - 2019 (USD Million)

Chapter 7 Endocrine Testing Market, by Geography

  • 7.1 Overview
    • 7.1.1 Global Endocrine Testing Market, by Geography 2011 - 2019 (USD Million)
  • 7.2 North America
    • 7.2.1 North America Endocrine Testing Market, 2011 - 2019 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe Endocrine Testing Market, 2011 - 2019 (USD Million)
  • 7.4 Asia-Pacific
    • 7.4.1 Asia-Pacific Endocrine Testing Market, 2011 - 2019 (USD Million)
  • 7.5 Rest of the World (RoW)
    • 7.5.1 RoW Endocrine Testing Market, 2011 - 2019 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Market Share by Key Players: Global Endocrine Testing Market, 2012 (%)
    • 8.1.1 Global Endocrine Testing Market Share Analysis, by Key Players, 2012 (%)

Chapter 9 Recommendations

  • 9.1 Market strategies for success
  • 9.2 Barriers to be considered

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
    • 10.1.1 Company Overview
    • 10.1.2 Financial Overview
    • 10.1.3 Product Portfolio
    • 10.1.4 Business Strategies
    • 10.1.5 Recent Developments
  • 10.2 AB SCIEX LLC
    • 10.2.1 Company Overview
    • 10.2.2 Financial Overview
    • 10.2.3 Product Portfolio
    • 10.2.4 Business Strategies
    • 10.2.5 Recent Developments
  • 10.3 Agilent Technologies
    • 10.3.1 Company Overview
    • 10.3.2 Financial Overview
    • 10.3.3 Product Portfolio
    • 10.3.4 Business Strategies
    • 10.3.5 Recent Developments
  • 10.4 Biomedical Diagnostics
    • 10.4.1 Company Overview
    • 10.4.2 Financial Overview
    • 10.4.3 Product Portfolio
    • 10.4.4 Business Strategies
    • 10.4.5 Recent Developments
  • 10.5 bioMerieux
    • 10.5.1 Company Overview
    • 10.5.2 Financial Overview
    • 10.5.3 Product Portfolio
    • 10.5.4 Business Strategies
    • 10.5.5 Recent Developments
  • 10.6 Bio-Rad Laboratories, Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Financial Overview
    • 10.6.3 Product Portfolio
    • 10.6.4 Business Strategies
    • 10.6.5 Recent Developments
  • 10.7 DiaSorin S.p.A
    • 10.7.1 Company Overview
    • 10.7.2 Financial Overview
    • 10.7.3 Product Portfolio
    • 10.7.4 Business Strategies
    • 10.7.5 Recent Developments
  • 10.8 F. Hoffmann-La Roche Ltd.
    • 10.8.1 Company Overview
    • 10.8.2 Financial Overview
    • 10.8.3 Product Portfolio
    • 10.8.4 Business Strategies
    • 10.8.5 Recent Developments
  • 10.9 Laboratory Corporation of America Holdings (LabCorp)
    • 10.9.1 Company Overview
    • 10.9.2 Financial Overview
    • 10.9.3 Product Portfolio
    • 10.9.4 Business Strategies
    • 10.9.5 Recent Developments
  • 10.10 Ortho Clinical Diagnostics
    • 10.10.1 Company Overview
    • 10.10.2 Financial Overview
    • 10.10.3 Product Portfolio
    • 10.10.4 Business Strategies
    • 10.10.5 Recent Developments
  • 10.11 Quest Diagnostics
    • 10.11.1 Company Overview
    • 10.11.2 Financial Overview
    • 10.11.3 Product Portfolio
    • 10.11.4 Business Strategies
    • 10.11.5 Recent Developments
  • 10.12 Siemens Healthcare
    • 10.12.1 Company Overview
    • 10.12.2 Financial Overview
    • 10.12.3 Product Portfolio
    • 10.12.4 Business Strategies
    • 10.12.5 Recent Developments
  • 10.13 Sysmex Corporation
    • 10.13.1 Company Overview
    • 10.13.2 Financial Overview
    • 10.13.3 Product Portfolio
    • 10.13.4 Business Strategies
    • 10.13.5 Recent Developments
  • 10.14 Thermo Fisher Scientific
    • 10.14.1 Company Overview
    • 10.14.2 Financial Overview
    • 10.14.3 Product Portfolio
    • 10.14.4 Business Strategies
    • 10.14.5 Recent Developments

List of Figures

  • FIG. 1 Endocrine Testing: Market Segmentation
  • FIG. 2 Global Endocrine Testing Market, by Test, 2012 (USD Million)
  • FIG. 3 Global Endocrine Testing Market, by Diagnostic Technology, 2012 (USD Million)
  • FIG. 4 Introduction to Endocrine Glands/organs
  • FIG. 5 Global Rate of Aging Population
  • FIG. 6 Porter's Five Forces Analysis: Global Endocrine Testing Market
  • FIG. 7 Market Attractiveness Analysis: Global Endocrine Testing Market, by Geography
  • FIG. 8 Global Estradiol (E2) Test Market, 2011 - 2019 (USD Million)
  • FIG. 9 Global Follicle Stimulating Hormone (FSH) Test Market, 2011 - 2019 (USD Million)
  • FIG. 10 Global Human Chorionic Gonadotropin (hCG) Test Market, 2011 - 2019 (USD Million)
  • FIG. 11 Global Luteinizing Hormone (LH) Test Market, 2011 - 2019 (USD Million)
  • FIG. 12 Global Dehydroepiandrosterone Sulfate (DHEAS) Test Market, 2011 - 2019 (USD Million)
  • FIG. 13 Global Progesterone Test Market, 2011 - 2019 (USD Million)
  • FIG. 14 Global Testosterone Test Market, 2011 - 2019 (USD Million)
  • FIG. 15 Global Thyroid Stimulating Hormone (TSH) Test Market, 2011 - 2019 (USD Million)
  • FIG. 16 Global Prolactin Test Market, 2011 - 2019 (USD Million)
  • FIG. 17 Global Cortisol Test Market, 2011 - 2019 (USD Million)
  • FIG. 18 Global Insulin Test Market, 2011 - 2019 (USD Million)
  • FIG. 19 Global Others Market, 2011 - 2019 (USD Million)
  • FIG. 20 Global Tandem Mass Spectrometry Market, 2011 - 2019 (USD Million)
  • FIG. 21 Global Immunoassay Technologies Market, 2011 - 2019 (USD Million)
  • FIG. 22 Global Monoclonal and Polyclonal Antibody Technologies Market, 2011 - 2019 (USD Million)
  • FIG. 23 Global Sensor Technologies Market, 2011 - 2019 (USD Million)
  • FIG. 24 Global Clinical Chemistry Technologies Market, 2011 - 2019 (USD Million)
  • FIG. 25 Global Others Market, 2011 - 2019 (USD Million)
  • FIG. 26 Global Hospitals Market, 2011 - 2019 (USD Million)
  • FIG. 27 Global Commercial Laboratories Market, 2011 - 2019 (USD Million)
  • FIG. 28 Global Ambulatory Care Centers Market, 2011 - 2019 (USD Million)
  • FIG. 29 Global Home Based Tests Market, 2011 - 2019 (USD Million)
  • FIG. 30 Global Physician Offices Market, 2011 - 2019 (USD Million)
  • FIG. 31 North America Endocrine Testing Market, 2011 - 2019 (USD Million)
  • FIG. 32 Europe Endocrine Testing Market, 2011 - 2019 (USD Million)
  • FIG. 33 Asia-Pacific Endocrine Testing Market, 2011 - 2019 (USD Million)
  • FIG. 34 RoW Endocrine Testing Market, 2011 - 2019 (USD Million)
  • FIG. 35 Endocrine Testing: Market Share, by Key Players, 2012 (%)
  • FIG. 36 Abbott Laboratories, Inc., Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 37 Agilent Technologies, Annual Revenue: 2010 - 2012 (USD million,)
  • FIG. 38 bioMerieux, Annual Sales Revenue: 2010 - 2012 (USD Million) Conversion Rate 1Euro = 1.34 USD
  • FIG. 39 Bio-Rad, Annual Sales Revenue : 2010 - 2012 (USD Million)
  • FIG. 40 DiaSorin, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 41 F. Hoffmann-La Roche Ltd.: Annual Revenues, 2010 - 2012 (USD Million)
  • FIG. 42 LabCorp: Annual Revenue, 2010 - 2012 (USD Million)
  • FIG. 43 Ortho Clinical Diagnostics, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 44 Quest Diagnostics, Annual Revenue: 2010 - 2012 (USD Million)
  • FIG. 45 Siemens Healthcare, Annual Revenue: 2010 - 2012 (USD Billion)
  • FIG. 46 Sysmex Corporation, Annual Sales: 2011 - 2013 (USD million)
  • FIG. 47 Thermo Fisher Scientific, Annual Revenue: 2010 - 2012 (USD million)

List of Tables

  • TABLE 1 List of Abbreviations
  • TABLE 2 Market Snapshot: Global Endocrine Testing Market (2012 & 2019)
  • TABLE 3 Impact Analysis of Market Drivers
  • TABLE 4 Impact Analysis of Market Restraints
  • TABLE 5 Global Endocrine Testing Market, by Test, 2011 - 2019 (USD Million)
  • TABLE 6 Estradiol Test Result Range
  • TABLE 7 The Reasons For Performing FSH Test
  • TABLE 8 Progesterone Test Result Range
  • TABLE 9 Global Endocrine Testing Market, by Diagnostic Technologies 2011 - 2019 (USD Million)
  • TABLE 10 Global Endocrine Testing Market, by Ed Users 2011 - 2019 (USD Million)
  • TABLE 11 Global Endocrine Testing Market, by Geography 2011 - 2019 (USD Million)
Back to Top